Given that some of these molecules associate with amyloid-beta (Aβ) production, Tau phosphorylation and regulation of BACE1 and amyloid precursor protein (APP) expression [69,74,78], such dysregulations may lead to the aggravation of AD pathology. Here, MAPT is linked to Alzheimer disease.